| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 3.9186 | 13 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 3.69217 | 7 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 7.59786 | 77 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 3.9005 | 13 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 4.751 | 35 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 5.38401 | 49 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 5.93638 | 57 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 3.81726 | 11 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 4.44137 | 27 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 4.21623 | 22 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 4.26539 | 24 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 4.3098 | 24 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 5.88023 | 57 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 5.24873 | 46 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 4.90227 | 39 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 4.6799 | 34 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 4.87666 | 39 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 5.2358 | 45 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 5.39666 | 48 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 4.98646 | 37 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 3.79833 | 10 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 4.23747 | 23 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 4.48231 | 30 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 4.71341 | 35 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 4.53233 | 30 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 5.71484 | 54 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 4.84005 | 37 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.85141 | 37 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.03715 | 17 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 5.84042 | 55 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 5.27816 | 46 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 5.9947 | 58 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 3.7847 | 9 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 4.20314 | 22 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 6.04321 | 59 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 5.12346 | 44 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 5.94874 | 57 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 4.41972 | 27 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 4.1576 | 20 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 6.90422 | 69 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 4.48453 | 29 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 6.27027 | 62 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 6.51268 | 65 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 5.8746 | 56 |